Attack Mounts on Drug Prices

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-09-02-2002, Volume 26, Issue 9

Congress debates legislation for a Medicare drug benefit while the industry expresses concerns about import control, drug counterfeiting, and patent rights.

Related Content:

Quality SystemsRegulatory WatchPharmaceutical Technology-09-02-2002
Gilead Treatment for PBC Granted EC Conditional Marketing Authorization
Ask the Expert: Complying with 21 CFR 211.110
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment